Skip to main content

Table 1 Characteristics of IBMs studies for infectious disease transmission published from 2006 to 2015

From: Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)

Topic

Count

Purpose

Strategy

Economic

Pathogen

Type

 

Methods

Dynamics

Interventions

Vaccine

NPI

Drugs

Screening

Analysis

Unspecified Close-contact

General

186

95

77

14

5

9

1

-

4

Unspecified STI

General

9

3

5

1

1

1

-

1

-

Unspecified Vector-borne

General

7

7

-

-

-

-

-

-

-

Bioterrorism

General

6

3

1

2

-

2

1

-

1

Influenza

Viral

161

51

37

73

37

47

24

3

14

HIV

Viral

91

25

25

41

3

12

25

15

23

HPV

Viral

27

2

2

23

23

-

-

7

15

Hepatitis C

Viral

12

2

3

7

1

-

6

2

3

Ebola

Viral

8

-

5

3

1

3

2

-

-

SARS

Viral

8

4

3

1

1

-

-

1

-

Smallpox

Viral

7

-

-

7

7

3

-

3

-

Measles

Viral

5

1

1

3

3

-

-

1

-

Polio

Viral

4

1

2

1

1

-

-

-

-

HIV+Hepatitis C

Viral

3

1

1

1

-

1

-

-

-

HIV+HSV

Viral

3

-

1

2

1

-

1

-

1

Varicella Zoster

Viral

3

1

2

-

-

-

-

-

-

Respiratory syncytial virus

Viral

2

-

-

2

2

-

-

-

1

Acute hemorrhagic conjunctivitis

Viral

2

2

-

-

-

-

-

-

-

Hepatitis A

Viral

1

-

-

1

1

3

-

-

-

Norovirus

Viral

1

-

1

-

-

-

-

-

-

Malaria

Vector-borne

35

7

5

23

7

1-

11

3

5

Dengue

Vector-borne

13

4

5

4

2

3

-

-

-

Chikungunya

Vector-borne

1

-

-

1

-

1

-

-

-

Schistosoma

Parasitic

3

2

1

-

-

-

-

-

-

Wuchereria

Parasitic

3

2

-

1

-

1

1

-

-

Helminths

Parasitic

2

-

1

1

-

-

1

-

-

Onchocerca

Parasitic

2

-

-

2

-

-

2

-

1

Chagas disease

Parasitic

1

1

-

-

-

-

-

-

-

Toxocara

Parasitic

1

-

1

-

-

-

-

-

-

Cryptosporidium

Parasitic

1

1

-

-

-

-

-

-

-

Tuberculosis

Bacterial

26

8

6

12

-

-

9

9

4

MRSA

Bacterial

14

3

2

9

-

13

2

4

1

Chlamydia

Bacterial

7

3

-

4

1

-

-

3

1

Nosocomial infections

Bacterial

7

3

2

2

1

4

-

-

-

Syphilis

Bacterial

6

-

-

6

-

2

1

4

1

Pneumococcus

Bacterial

5

1

1

3

2

1

-

-

-

Cholera

Bacterial

4

-

4

-

-

-

-

-

-

Lepra

Bacterial

4

-

2

2

1

-

2

1

-

Gonorrhoea

Bacterial

3

-

1

2

1

-

-

1

-

Clostridium difficile

bacterial

3

-

-

3

-

7

2

2

-

Pertussis

bacterial

3

-

1

2

2

-

-

-

1

Meningococcus

bacterial

3

1

1

1

1

-

-

-

-

Acinetobacter baumannii

bacterial

1

-

-

1

-

2

-

-

-

Enterococcus

bacterial

1

-

1

-

-

-

-

-

-

Typhoid

bacterial

1

-

1

-

-

-

-

-

-

Mycobacterium ulcerans

bacterial

1

-

1

-

-

-

-

-

1

Foot and mouth disease

zoonose

1

1

-

-

-

-

-

-

-

Total

 

698

235

202

261

105

125

91

60

77

  1. Each study was assigned one purpose, which is cumulative from methods, dynamics to intervention (e.g., studies about interventions can also describe dynamics and methods). The category “NPI” includes all non-pharmaceutical intervention strategies such as social distancing, school closure and improving standards of living and (hand-)hygiene. HIV: human immunodeficiency virus, HPV: human papillomavirus, HSV: herpes simplex virus, MRSA: methicillin-resistant S. aureus, STI: sexually transmitted infection
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us